The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology

10.1083/jcb.40.3.648

10.1016/0166-2236(90)90043-A

10.7326/0003-4819-105-1-82

10.1146/annurev.neuro.22.1.11

10.1161/01.STR.30.9.1916

10.1016/S0006-8993(01)02637-3

10.1016/S0049-3848(00)00218-8

Grant GA, 1998, News Physiol Sci, 13, 287

Skoog I, 1999, Alzheimer Dis Ass Disord, 13, S106—S114

Janigro D, 1993, Am I Physiol, 265, C812—C821

Janigro D, 1996, Am J Physiol, 270, H1423—H1434

Janigro D, 1997, Am J Physiol, 273, 878

10.1111/j.1749-6632.1994.tb17311.x

10.1073/pnas.83.7.2114

10.1161/01.RES.72.2.239

Davies PF, 1995, Physiol Rev, 75, 519, 10.1152/physrev.1995.75.3.519

10.1161/01.RES.86.2.185

10.1161/01.HYP.31.1.162

Resnick N, 1995, Gene Ther, 9, 874

10.1038/362801a0

Nerem RM, 1992, J Biochem Eng, 114, 274

10.1161/01.RES.79.1.32

10.1073/pnas.90.13.5999

10.1073/pnas.94.17.9308

10.1172/JCI118455

10.1073/pnas.92.17.8069

10.1080/10623320212004

10.1146/annurev.cb.11.110195.000445

10.1038/386671a0

Risau W, 1988, Development, 102, 471, 10.1242/dev.102.3.471

Flamme I, 1992, Development, 116, 435, 10.1242/dev.116.2.435

10.1172/JCI118454

10.1126/science.275.5302.964

10.1038/386488a0

Choi K, 1998, Development, 125, 725, 10.1242/dev.125.4.725

10.1038/380439a0

10.1038/376062a0

Flamme I, 1992, Development, 116, 435, 10.1242/dev.116.2.435

10.1172/JCI118454

Civin Cl, 1984, J Immunol, 133, 157, 10.4049/jimmunol.133.1.157

Ito A, 1995, Lab Invest, 72, 532

10.1016/0092-8674(93)90573-9

Yamaguchi TP, 1993, Development, 118, 489, 10.1242/dev.118.2.489

10.1073/pnas.90.16.7533

Schnurch H, 1993, Development, 119, 957, 10.1242/dev.119.3.957

10.1038/376070a0

Folkman J, 1992, J Biol Chem, 267, 10931, 10.1016/S0021-9258(19)49853-0

10.1161/01.RES.85.3.221

10.1182/blood.V99.2.457

10.1073/pnas.92.11.4857

10.1161/01.CIR.0000046450.89986.50

10.1161/01.RES.0000056757.93432.8C

Shi Q, 1998, Blood, 92, 362, 10.1182/blood.V92.2.362

Xu F, 1998, Zhonghua Xue Ye Xue Za Zhi, 19, 274

Yin AH, 1997, Blood, 90, 5002, 10.1182/blood.V90.12.5002

10.1161/01.RES.88.2.167

10.1634/stemcells.19-4-304

10.1016/0092-8674(93)90573-9

10.1126/science.1690453

Cines DB, 1998, Blood, 91, 3527

Hatzopoulos AK, 1998, Development, 125, 1457, 10.1242/dev.125.8.1457

Nishikawa SI, 1998, Development, 125, 1747, 10.1242/dev.125.9.1747

10.1172/JCI118872

10.1172/JCI8774

Peichev M, Naiyer AJ, Pareira D, et a/. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors, (2000)

Rehman J, 2003, Peripheral blood ‘endothelial progenitor cells’ are derived from monocyte/macrophages and secrete angiogenic growth factors

Socinski MA, 1988, Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man

Clark SC, 1987, The human hematopoietic colony-stimulating factors

Dedhar S, 1988, Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin

Bussolino F, 1989, Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate

10.1038/337471a0

Soldi R, Primo L, Brizzi MF, et a/. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor, (1997)

10.1038/376062a0

10.1038/nm0398-336

10.1038/380439a0

10.1093/emboj/18.14.3964

Barleon B, 1996, Blood, 87, 3336, 10.1182/blood.V87.8.3336.bloodjournal8783336

10.1126/science.6823562

Griffioen AW, 1996, Blood, 88, 667, 10.1182/blood.V88.2.667.bloodjournal882667

10.1038/nm0996-992

Senger DR, 1996, Am J Pathol, 149, 293

10.1161/01.RES.86.12.1198

Duhrsen U, 1988, Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients

Donahue RE, 1996, Blood, 87, 1644, 10.1182/blood.V87.4.1644.bloodjournal8741644

Kim CH, 1998, Blood, 91, 100, 10.1182/blood.V91.1.100

10.1046/j.1365-2141.1996.d01-1835.x

10.1161/hc2301.092122

10.1073/pnas.97.7.3422

10.1161/01.CIR.103.5.634

10.1038/86498

10.1161/01.CIR.0000046450.89986.50

10.1172/JCI6889

10.1016/S0140-6736(96)03361-2

10.1161/01.CIR.97.12.1114

10.1161/01.CIR.98.25.2800

10.1074/jbc.274.23.16349

10.1172/JCI1560

10.1074/jbc.270.52.31189

10.1161/01.CIR.99.1.111

10.1161/01.CIR.99.24.3188

10.1016/S0002-9440(10)65282-0

10.1161/01.CIR.96.8.2667

10.1016/S0741-5214(98)70022-9

Takeshita S, 1996, Lab Invest, 75, 487

10.1073/pnas.97.7.3422

Gabrilovich D, 1998, Blood, 92, 4150, 10.1182/blood.V92.11.4150

10.1038/nm1096-1096

10.1038/nm1101-1194

10.1161/01.RES.87.9.728

10.1038/sj.gt.3301883

10.1161/01.RES.81.3.328

10.1056/NEJM198112173052501

10.1161/hh1301.093953

10.1161/01.CIR.0000043246.74879.CD

10.1161/hc0602.103673

10.1126/science.282.5391.1145

10.1055/s-2000-12560